Your session is about to expire
← Back to Search
COPE+ Program for Cancer Patients with Cognitive Impairment
Study Summary
This trial is testing whether programs that include both a cancer patient and their spouse or family caregiver are helpful for families when the cancer patient has mild memory difficulties. Participants will have six, 60-minute video-conference sessions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 65 or older with a recent diagnosis of breast, colon, rectal, or lung cancer.I have dementia and cannot make decisions for myself.I live with the patient or spend 3-4 hours a day caring for them.I do not have severe visual or hearing impairments that would stop me from participating.I am a caregiver and I am 18 years old or older.
- Group 1: Patient Caregiver Dyad
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the trial accept elderly participants?
"To be admitted into this medical trial, applicants must fall within the age bracket of 18 to 100. Meanwhile, 89 studies cater to minors and 997 studies focus on those aged over 65."
Are there any opportunities to join this clinical experiment currently available?
"Data retrieved from clinicaltrials.gov has confirmed that, while this medical trial was originally published on October 1st 2023 and last amended on 10/6/2022, it is no longer actively enrolling patients. Nevertheless, there are still over a thousand other trials presently recruiting participants."
Am I eligible to take part in this clinical trial?
"This clinical trial is searching for 144 people with a malignancy between the ages of 18 and 100. To be eligible, participants must possess fluency in English and demonstrate competence using tablet computers to take part in video conferences. Furthermore, patients should have Stage I-IV breast, colon, rectal or lung cancer (diagnosed within 6 months), exhibit Mild cognitive impairment/Concerns and cohabit or spend at least 3-4 hours per day providing caregiving services to the patient. Additionally, they are required to have an informal family caregiver who is over 18 years old and not suffer from cognitive impairment themselves."
What is the desired outcome of this research?
"The primary assessment of this trial, measured over the course of 10 weeks, will be patient satisfaction determined by a score on CSQ-8 greater than 24. Secondary outcomes include quality of life as gauged by FACT-G (0-108), distress levels assessed through DASS-21 (0 - 63) and relationship satisfaction evaluated with Mutuality Scale from Family Care Inventory (0 - 60)."
Share this study with friends
Copy Link
Messenger